Product Reports Resources Pricing Login Book a demo

Mammoth Biosciences

Biotech & Life Sciences · Brisbane, United States · Founded 2017

The CRISPR-based platform for disease detection

Investors

19 investors on Mammoth Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 2 investors entered at this stage
Series A 4 investors entered at this stage
8VC
Kairos
Tectonic Capital
Mayfield
Series B+ 13 investors entered at this stage
Plum Alley
Foresite Capital
Pacific 8 Ventures
Senator Investment Group
Brook Byers
Redmile Group
Sixth Street Growth
Regeneron Pharmaceuticals
University of California
Berkeley
Greenspring Associates
aMoon Fund
Decheng Capital

Ownership

Who owns Mammoth Biosciences

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

27% Founders
  • NFX 11.5%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Mammoth Biosciences has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States98.2%
🇸🇬 Singapore0.8%
🇦🇺 Australia0.8%
🇬🇧 United Kingdom0.8%
4 countries shown
Web traffic by country
14K monthly visits
across markets
🇺🇸 United States70%
🇮🇳 India15.7%
🇪🇸 Spain5%
🇬🇧 United Kingdom3.6%
🇧🇩 Bangladesh2.1%
Top 5 markets shown

Talent graph

The shape of Mammoth Biosciences's talent

Dealroom maps Mammoth Biosciences's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

7 standout operatorsDealroom-flagged across the org
4 AI specialistsincl. 1 core researchers
160 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Mammoth Biosciences's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$23M patent portfolio · 46 active families

Estimated portfolio value
$23M
2.3% of valuation · 5.5× smaller than top peer Zymeworks ($125M)
46 active patent families
Where Mammoth Biosciences innovates BioinformaticsBiophysicsCRISPREffectorGuide RNA

Where Mammoth Biosciences concentrates vs peers

Each axis is a top-10 topic across Mammoth Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Mammoth Biosciences

An AI-synthesized read of the highest-engagement posts about Mammoth Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mammoth Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.